Skip to main content

Table 6 Simple Tobit regression (left ear)

From: Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity

Frequency (Hz) No. of non-responses Variables
Estimate of coefficient (SE); p-value
Age HIV seropositive NCD
LFPTT
125 1 0.36 (0.12); 0.01 0.95 (2.77); 0.73 3.51 (3.14 (0.26)
250 0 0.41 (0.13); 0.01 0.71 (3.04); 0.82 3.5 (3.42); 0.31
500 0 0.4 (0.14); 0.01 0.36 (3.28); 0.91 4 (3.76); 0.28
MFPTT
1000 0 0.42 (0.16); 0.01 0.88 (3.56); 0.8 3.21 (4.02); 0.42
2000 0 0.55 (0.16); 0.01 2.21 (3.66); 0.55 3.25 (4.11); 0.43
HFPTT
4000 1 0.91 (0.17); 0.01 7.14 (4.29); 0.09 7.26 (4.89); 0.14
8000 0 1.11 (0.2); 0.01 9.77 (5.07); 0.05 1.62 (5.77); 0.01
9000 1 1.33 (0.19); 0.01 16.11 (4.92); 0.001 4.13 (5.82); 0.48
EHFPTT
10,000 3 1.64 (0.19); 0.01 21.23 (5.28); 0.01 5.25 (6.58); 0.42
11,200 5 1.95 (0.19); 0.01 25.3 (5.61); 0.01 0.54 (7.15); 0.94
12,500 12 (14.6%) 2.02 (0.19); 0.01 26.4 (5.76); 0.01 − 1.81 (7.36); 0.81
14,000 23 (28%) 1.85 (0.21); 0.01 22.37 (5.76); 0.01 4.38 (7.16); 0.54
16,000 50 (61%) 0.92 (0.23); 0.01 12.93 (4.81); 0.01 6.87 (5.67); 0.22
18,000 68 (83%) 0.71 (0.46); 0.13 6.1 (9.42); 0.52 11.85 (9.62); 0.22
20,000 73 (89%) 0.23 (0.21); 0.26 1.81 (4.34);0.68 4.74 (4.99);0.34
  1. LFPTT, Low frequency pure tone thresholds; MFPTT, Mid frequency pure tone thresholds; HFPTT, High frequency pure tone thresholds; EHFPTT, Extended high frequency pure tone thresholds; NCD, Hypertension and Diabetes